Four days on, three days off HIV treatment controls viral load in French pilot study
Darunavir/ritonavir & lamivudine matches triple-drug therapy
New long-acting fusion inhibitor albuvirtide plus boosted protease inibitor matches standard triple-drug therapy
Generic hepatitis C drugs purchased online achieve high cure rates
Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels
The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears
French study reveals the growing complexity of medical needs as people with HIV age
Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk
Two-drug HIV therapy just as effective as three-drug therapy
New $90-$90-$90 target needed for global viral hepatitis, HIV and TB treatment
